ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

6 links0 made here, not in the record11 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT02996110A Study to Test CombinationTreatments in People WithAdvanced Renal CellCarcinomaBristol-Myers SquibbPhase 2 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSAdvanced CancerNo longer in the registry's filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseDRUGSNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerIpilimumabIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorRelatlimabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedLinrodostatEntry “BMS-986205”, read by our name …›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedBMS-813160Intervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Nivolumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Nivolumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Background · partner
Background · partner · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2NivolumabClaude Opus 5.5Background · partnerCurrent
Nov 2IpilimumabClaude Opus 5.5ComparatorCurrent
Nov 2RelatlimabClaude Opus 5.5TestedCurrent
Nov 2LinrodostatClaude Opus 5.5TestedCurrent
Nov 2BMS-813160Claude Opus 5.5TestedCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 14Advanced CancerRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 18NivolumabRule based · role ruleBackgroundAgrees
Nov 18IpilimumabRule based · role ruleComparatorAgrees
Nov 18RelatlimabRule based · role ruleTestedAgrees
Nov 18LinrodostatRule based · role ruleTestedAgrees
Nov 18BMS-813160Rule based · role ruleTestedAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.